Tetrahydrozoline (Tetryzoline)

DEA Class;  OTC

Common Brand Names; Visine Advanced Relief, Visine Maximum Redness Relief, Visine Original, Rohto Arctic

May stimulate alpha-adrenergic receptors in the arterioles of the conjunctiva; produces vasoconstriction

May produce mydriasis when applied to the conjunctiva, but this effect is usually minimal with the concentrations used as ocular decongestants

Irritation/burning

Blurred vision

Headache

Tremor

Hypertension

Tachycardia

Palpitation

Ask a doctor or pharmacist if Visine Advanced Relief is safe to use if you have ever had glaucoma

May cause temporary mydriasis

Use caution in hypertension, coronary artery disease, diabetes, and hyperthyroidism

Discontinue and seek medical advice if the following occur: eye pain, changes in vision, redness or irritation of the eye lasts >72 hr

Wash hands before using eye medication

To be used exactly as directed on label, or as prescribed by the doctor

Not for use while wearing soft contact lenses; a preservative in this medication could permanently stain lenses; use medicine at least 15 minutes before inserting contact lenses

Use only the number of drops recommended on label

Do not touch tip of eye dropper or place it directly on eye; a contaminated dropper can infect the eye, which could lead to serious vision problems

Do not use if medication has changed colors or looks cloudy

Pregnancy

Ask healthcare professional

Lactation

Ask healthcare professional

Adults

1-2 gtt to affected eye q6-12hr

Not to exceed 72 hours of use

Administration

Remove contact lenses before use

Do not use if this solution changes color or becomes cloudy

Do not touch tip of container to any surface to avoid contamination

Replace cap after each use

Children

Safety and efficacy not established.

Tetrahydrozoline (Tetryzoline)

Eye Drops